Professional Documents
Culture Documents
Nama
Dr.Esti Nurekasari
Pembimbing
Dr. Didik., Sp.PD
ABSTRACT
• Purpose: We report the outcomes in patients with muscle invasive bladder cancer from 2 institutions
who experienced a clinically complete response to neoadjuvant platinum based chemotherapy and
elected active surveillance. It was unknown whether conservative treatment could be safely
implemented in these patients.
• Materials and Methods: We retrospectively reviewed the records of patients with muscle
invasive bladder cancer at our institutions who elected surveillance following a clinically complete
response to transurethral resection of bladder tumors and neoadjuvant chemotherapy from 2001 to
2017. A clinically complete response was defined as absent tumor on post-chemotherapy transurethral
resection of bladder tumor, negative cytology and normal cross-sectional imaging.
• Results: In the 148 patients followed a median of 55 months (range 5 to 145) the 5-year disease
specific, overall, cystectomy-free and recurrence-free survival rates were 90%, 86%, 76% and 64%,
respectively. Of the patients 71 (48%) experienced recurred in the bladder, including 16 (11%) with
muscle invasive disease and 55 (37%) with noninvasive disease. Salvage radical cystectomy prevented
cancer specific death in 9 of 12 patients (75%) who underwent cystectomy after muscle invasive relapse
and in 13 of 14 (93%) after noninvasive relapse.
• Conclusions: We observed high rates of overall and disease specific survival with bladder
preservation in patients who achieved a clinically complete response to neoadjuvant chemotherapy.
These outcomes support the safety of active surveillance in carefully selected, closely monitored
patients with muscle invasive bladder cancer. Future studies should aim to improve patient selection by
identifying biomarkers predicting invasive relapse and developing novel imagingmethods of early
detection.
PENDAHULUAN
Standar baku emas untuk pasien kanker saluran kemih
adalah NAC diikuti dengan RC dan pevic lifadenektomi
Follow up
• Pemeriksaan fisik, sistoskopi,sitology dilakukan 2-3 bulan
selama 2 tahun
• CT crosssectional imaging setiap 4-6 bulan selama 2 tahun
• Setelah 5 tahun sistoskopi dan pencitraan dilakukan setiap
tahun sekali.
METODE PENELITIAN
Analisis
• Analisis OS,DSS, cystectomy-free, dan recurrence-free
survival menggunakan Kaplan-Meier.
• Pasien dengan karakteristik yg berhubungan dengan DSS dan
rekurensi invasive otot menggunakan analisis univariate
METODE PENELITIAN
Analisis
• Evaluasi hubungan antara waktu dengan rekurensi intravesikal dan
variable independent yang berhubungan dengan klinis (usia,
konsistensi tumor(pappilary vs solid), CIS, dan invasi limfovaskular
menggunakan analisis COX proportional hazards model
HASIL
HASIL
Pasien dengan MIBC
berulang menunjukkan
buruknya kemampuan
bertahan hidup
dibanding dengan
pasien tanpa invasive
otot kandung kemih
berulang
HASIL
Terdapat hubungan
yang kuat antara
adanya hidronefrosis
dengan kematian
akibat kanker
kantung kemih
HASIL
Terdapat
hubungan antara
terdiagnosisnya
hidronefrosis
sebelum terapi
dengan kejadian
rekurensi invasive
otot kandung
kemih
HASIL
HASIL
Terdapat 37(25%) pasien yang
meninggal dan 111(75%)
bertahan hidup selama 110
bulan (95% CI 101-119)
Selama 5 tahun terdapat 91
(82%) bertahan hidup
DISKUSI
• Pasien dengan MIBC yang mengalami cCR dan dilakukan TURBT serta NAC
memiliki DDS dan OS yang tinggi ketika di terapi dengan pengawasan
ketat.